To prove FXR’s critical role in mediating the Zbtb18-induced protective effects against lipid and glucose metabolic disorders, we employed FXR gain or loss cultured MPHs and HFD-fed mice combining them with hepatic Zbtb18 alterations. The gene discussed is NR1H4; the disease is glucose metabolism disease.